Carl F. Juneau MD

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

2345 E Prater WaySte 215Sparks, NV 89434
Phone+1 775-424-1090

Dr. Juneau is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Juneau's full profile Already have an account?

Summary

Dr. Carl Juneau is a cardiologist based in Reno, NV, with subspecialties in Cardiac Electrophysiology, and Interventional Cardiology. He completed his internal medicine education at McGill University and further specialized in cardiovascular disease through fellowships at the University of California, San Diego, and the University of Montreal. Dr. Juneau has expertise in valvular heart disease, interventional cardiology, cardiac catheterization, and cardiac critical care. He has made scholarly contributions, including a publication on the mechanical properties of papillary muscle in cardiac failure. Recognized for his meaningful use of electronic health records, he has received multiple certifications from eClinicalWorks. Additionally, he is a Fellow of the American College of Cardiology.

Education & Training

Faculty of Medicine. University of MontrealCardiovascular Disease, 1991 - 1992
University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 1987 - 1990
McGill University Faculty Medicine HospitalInternal Medicine, 1981 - 1984
Hôpital du Saint-SacrementInternal Medicine, 1980 - 1981
University of Ottawa Faculty of MedicineClass of 1980

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1988 - Present
HI State Medical License 2018 - 2028
NV State Medical License 2024 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

Publications & Presentations

PubMed

14 citations
Mechanical properties of papillary muscle in cardiac failure: importance of pathogenesis and of ventricle of origin.
Jean L. Rouleau, Carl Juneau, Hearther Stephens, Hossien Shenasa, William W. Parmley
Journal of Molecular and Cellular Cardiology. 1989-08-01

Press Mentions

State-Run Hospitals and Clinics Pay Some of Hawaii’s Highest Public WagesSeptember 27th, 2021
Room to Heal: New Building for Cancer Center, Second Cath Lab Among HHSC Improvement ProjectsJune 20th, 2021
How 2 Set Styles May Build Muscle in Half the TimeAugust 28th, 2020

Grant Support

Next generation T cell therapies for mutant KRAS solid tumorsUNIVERSITY OF PENNSYLVANIA2025–2028
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantationUNIVERSITY OF PENNSYLVANIA2021–2028
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantationUNIVERSITY OF PENNSYLVANIA2021–2028
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantationUNIVERSITY OF PENNSYLVANIA2021–2028
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantationUNIVERSITY OF PENNSYLVANIA2021–2028